ReviewAsian journal of andrology
Current medical management of endocrine-related male infertility.
Review in Asian journal of andrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 86 citations in OpenAlex.
- Use of Human Chorionic Gonadotropin (HCG) or HCG-Combined Treatments in Male Infertility: A Systematic Review.Cureus · 2025Review
- Inexpensive thermal containers and insulation materials prevent deterioration of semen parameters for less than 90 minutes.The Journal of reproduction and development · 2025Article
- Medical treatment prior to micro-TESE.Asian journal of andrology · 2025Review
- Artificial Intelligence in Andrology: A New Frontier in Male Infertility Diagnosis and Treatment.Current urology reports · 2025Review
- Phage Display Identified Novel Leydig Cell Homing Peptides for Testicular Targeting.ACS pharmacology & translational science · 2024Article
- Combination clomiphene citrate and anastrozole duotherapy improves semen parameters in a multi-institutional, retrospective cohort of infertile men.Translational andrology and urology · 2024Article
- Article
- Article
- Determining the content and needs assessment a mobile-based self-care program in infertile men.BMC medical informatics and decision making · 2023Article
- From Diagnosis to Treatment: Comprehensive Care by Reproductive Urologists in Assisted Reproductive Technology.Medicina (Kaunas, Lithuania) · 2023Review
- Current Progress in Stem Cell Therapy for Male Infertility.Stem cell reviews and reports · 2023Review
- Semen rheology and its relation to male infertility.Interface focus · 2022Review
- An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers.International journal of impotence research · 2022Review
- The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios.Translational andrology and urology · 2022Article
- Effect of Letrozole Administration as a Selective Aromatase Inhibitor on Male Rat's Reproductive Performance.Archives of Razi Institute · 2022Article
- Evaluation of selected semen parameters and biomarkers of male infertility - preliminary study.F1000Research · 2022Article
- Update on genetic screening and treatment for infertile men with genetic disorders in the era of assisted reproductive technology.Clinical and experimental reproductive medicine · 2021Article
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility.Journal of assisted reproduction and genetics · 2021Review
- Graphene and Reproduction: A Love-Hate Relationship.Nanomaterials (Basel, Switzerland) · 2021Review
- Lack of trusted diagnostic tools for undetermined male infertility.Journal of assisted reproduction and genetics · 2021Review
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male factor contributes to 50%-60% of overall infertility but is solely responsible in only 20% of couples. Although most male factor infertility is ascertained from an abnormal semen analysis, other male factors can be contributory especially if the sample returns normal. Male infertility can be due to identifiable hormonal or anatomical etiologies that may be reversible or irreversible. This manuscript will highlight existing guidelines and our recommendations for hormone evaluation for male infertility and empiric therapies including multivitamins, estrogen receptor modulators (clomiphene), estrogen conversion blockers (anastrozole), and hormone replacement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.